GlobeNewswire by notified

Basilea reports preliminary operating profit for 2022, significantly above guidance

Share
  • Successful implementation of strategic decision to focus on anti-infectives and stronger than expected revenue lead to profitability earlier than anticipated

Ad hoc announcement pursuant to Art. 53 LR

Basel/Allschwil, Switzerland, January 24, 2023

Basilea Pharmaceutica Ltd (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial or fungal infections, announced today that on an unaudited preliminary basis it expects to have achieved an operating profit of approximately CHF 18 million for the financial year 2022 and expects to report a net profit. Basilea had previously guided for an operating loss for 2022 of CHF 10 million to 15 million.

Adesh Kaul, Chief Financial Officer, commented: “Our strong 2022 financial performance is the result of the successful implementation of our strategic decision to focus on anti-infectives in combination with the continued commercial success of our marketed brands. Our financial strength puts us in an excellent position to build and maintain a balanced R&D portfolio of innovative drug candidates for the treatment of severe bacterial and fungal infections going forwards, to support the long-term growth of Basilea, and in so doing, execute on our strategy of becoming a leading anti-infectives company.”

In January 2023, Basilea announced that the unaudited total revenue for 2022 is expected to amount to approximately CHF 148 million, exceeding the previous full-year 2022 guidance of CHF 116 million to 122 million. The audited financial statements as well as the annual report 2022 will be published on February 14, 2023. The final audited revenue and the operating result for 2022 may differ from the preliminary numbers reported so far.

About Basilea

Basilea is a commercial-stage biopharmaceutical company founded in 2000 and headquartered in Switzerland. We are committed to discovering, developing and commercializing innovative drugs to meet the needs of patients with severe bacterial or fungal infections. We have successfully launched two hospital brands, Cresemba for the treatment of invasive fungal infections and Zevtera for the treatment of bacterial infections. In addition, we have several preclinical anti-infective assets in our portfolio. Basilea is listed on the SIX Swiss Exchange (SIX: BSLN). Please visit basilea.com.

Disclaimer

This communication expressly or implicitly contains certain forward-looking statements, such as "believe", "assume", "expect", "forecast", "project", "may", "could", "might", "will" or similar expressions concerning Basilea Pharmaceutica Ltd and its business, including with respect to the progress, timing and completion of research, development and clinical studies for product candidates. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of Basilea Pharmaceutica Ltd to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Basilea Pharmaceutica Ltd is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.

For further information, please contact:

Peer Nils Schröder, PhD

Head of Corporate Communications & Investor Relations
Basilea Pharmaceutica International Ltd, Allschwil
Hegenheimermattweg 167b
4123 Allschwil
Switzerland
Phone+41 61 606 1102
E-mailmedia_relations@basilea.com
investor_relations@basilea.com

This ad hoc announcement can be downloaded from www.basilea.com.

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

NNIT A/S: The Danish Business Authority has issued a decision requiring NNIT to update its accounting treatment of earn-out payments in the annual reports for 2020 and 202128.1.2023 17:18:54 CET | Press release

The Danish Business Authority has conducted a compliance review of NNIT A/S’ annual reports as stated in company announcement 12/2022. Following dialogue with NNIT, the Danish Business Authority has made a final decision affirming that the earn out payment related to the acquisition of Excellis Health Solutions should not be included in capitalized acquisition costs and goodwill, but instead expensed as remuneration as the earn out is in part subject to the selling shareholders’ continued employment during the accrual period. In consequence, NNIT is required to update its accounting treatment of earn-out payment in the annual reports from goodwill to special items as outlined below. A similar approach will be applied to the recognition of earn out payments for other acquisitions, including SCALES, Valiance Partner, HGP Group, SL Controls and prime4services. The technical changes to historical accounting policies will have no impact on total cash flow or the planned divestment of NNIT’s

Inside information: Digitalist Group’s subsidiary Digitalist Finland Oy has signed a term sheet for acquiring Walker & Handson Oy28.1.2023 13:00:00 CET | Press release

Digitalist Group Plc Inside information January 28nd, 2023 at 14:00 Inside information: Digitalist Group’s subsidiary Digitalist Finland Oy has signed a term sheet for acquiring Walker & Handson Oy Digitalist Group Plc (“Digitalist Group”) and its fully-owned subsidiary Digitalist Finland Oy have signed a term sheet (“LOI”) to an agreement (“Transaction”) in which Digitalist Finland Oy would acquire Walker & Handson Oy (“W&H”) to strengthen the management and tech & design business in Digitalist Finland Oy. In the intended Transaction Digitalist Finland Oy would acquire all shares in W&H through share exchange by issuing new Digitalist Finland Oy’s shares in a direct share issue to W&H representing approximately 10% of all shares in Digitalist Finland Oy after completion of the Transaction. The owner of W&H Jussi Hermunen will at the same time take over the position of Managing Director of Digitalist Finland Oy. Mr Jussi Hermunen would bring in solid experience of leading teams and bus

Hexagon Agility launches next generation Mobile Pipeline® modules with deliveries to Certarus28.1.2023 10:20:00 CET | Press release

28 January 2023: As previously disclosed, Hexagon Agility®, a business of Hexagon Composites, signed a multi-year agreement in March 2021 with Certarus, a leading full-service provider of bulk gas transport, to supply newly designed TITAN 450 Mobile Pipeline® modules. Hexagon Agility’s TITAN 450 modules represent the next generation of gas distribution modules and will be used to transport compressed and renewable natural gas (CNG/RNG) throughout North America. Under this agreement, Hexagon Agility has received a new USD 25.6 million (approx. NOK 253 million) order representing the inaugural order of Hexagon Agility’s new TITAN 450 modules. “We are proud to receive our first order for TITAN 450 from Certarus,” said Miguel Raimao, Vice President of Mobile Pipeline at Hexagon Agility. “Over 90% of the TITAN platform has been redesigned. The new TITAN 450 delivers 25% greater gas capacity, while being 20% lighter in the same 40-foot length. We appreciate our long-standing relationship wit

Brasilianska konkurrensmyndigheten godkänner försäljningen av Maha Energy Brasil27.1.2023 21:20:00 CET | Pressemelding

Maha Energy AB (publ) meddelar att brasilianska konkurrensmyndigheten (CADE) har, utan förbehåll, godkänt försäljningen av Maha Energy Brasil Ltda. till PetroRecôncavo S.A. Överlåtelseavtalet för försäljning av hela Mahas andel i Bolagets brasilianska dotterbolag offentliggjordes den 28 december och försäljningens genomförande villkorades av sedvanliga förbehåll, varav ett var godkännande av den brasilianska konkurrensmyndigheten. Denna information är sådan information som Maha Energy AB (publ) är skyldigt att offentliggöra enligt EU:s marknadsmissbruksförordning. Informationen lämnades, genom ovanstående kontaktpersons försorg, för offentliggörande den 27 januari, 2023 kl.21:20 CET För ytterligare information, kontakta: Paulo Thiago Mendonça, VD Telefon: +46 8 611 05 11 E-post: info@mahaenergy.ca Bernardo Guterres, CFO Telefon: +46 8 611 05 11 E-post: info@mahaenergy.ca Kort om Maha Maha Energy AB (publ) är ett listat, internationellt uppströmsolje- och gasbolag vars affärsverksamhet

Brazilian antitrust authority approves the sale of Maha Energy Brasil27.1.2023 21:20:00 CET | Press release

Maha Energy AB is pleased to announce that the Brazilian antitrust authority (CADE) has approved, without restrictions, the sale of Maha Energy Brasil Ltda. to PetroRecôncavo S.A. The quota purchase agreement for the sale of the entirety of Maha’s stake in its Brazilian subsidiary was announced on December 28, 2022, with its closing subject to other customary precedent conditions, the approval by the Brazilian antitrust authority being one of them. This information is such information as Maha Energy AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 21:20 CET, 27 January 2023 For more information, please contact: Paulo Thiago Mendonça, CEO Phone: +46 8 611 05 11 E-mail: info@mahaenergy.ca Bernardo Guterres, CFO Phone: +46 8 611 05 11 E-mail: info@mahaenergy.ca About Maha Maha Energy AB (publ) is a listed, international upstream oil and gas company whose